| Orchid Island Capital, Inc.: Orchid Island Capital Announces Second Quarter 2026 Results | VERO BEACH, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Orchid Island Capital, Inc. (NYSE: ORC) ("Orchid" or the "Company"), a real estate investment trust ("REIT"), today announced results of operations... ► Artikel lesen |
| Orchid Island Capital, Inc.: Orchid Island Capital Announces Estimated Second Quarter 2026 Results and June 30, 2026 RMBS Portfolio Characteristics | Estimated Book Value Per Share as of June 30, 2026 of $7.22Estimated GAAP net income of $0.44 per share for the quarter ended June 30, 2026 including an estimated $0.18 per share of net realized and... ► Artikel lesen |
| Orchid Island Capital, Inc.: Orchid Island Capital Announces July 2026 Monthly Dividend and Second Quarter 2026 Results Announcement Dates | July 2026 Monthly Dividend of $0.10 Per Share of Common StockEstimated Second Quarter 2026 Results and RMBS Portfolio Characteristics as of June 30, 2026 to be Released July 13, 2026Six Months Ended... ► Artikel lesen |
| 1GLOBAL führt "Verint Communications Analytics" ein, um die Cloud-Compliance in der Finanzbranche und in regulierten Branchen zu verbessern | 1GLOBAL bietet nun über "Verint Communications Analytics" eine speziell für Finanzmärkte und Handelsumgebungen entwickelte Lösung Transkriptionsdienste mit Einblicken in Mobilfunkgespräche in... ► Artikel lesen |
| 1GLOBAL Launches Verint Communications Analytics to Enhance Cloud Compliance for Financial and Regulated Industries | 1GLOBAL now offers transcription with insights into mobile calls in 10 countries on Verint Communications Analytics, built specifically for financial markets and trading environments Streamlines... ► Artikel lesen |
| Penumbra, Inc. Reports Second Quarter 2026 Financial Results | ALAMEDA, Calif., July 30, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the second... ► Artikel lesen |
| Penumbra, Inc.: First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke | ALAMEDA, Calif., July 7, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real... ► Artikel lesen |
| Penumbra, Inc.: Penumbra's THUNDERBOLT Receives FDA Clearance - Bringing Computer Assisted Vacuum Thrombectomy Technology to Stroke | THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke - enabling faster, more complete clot removal ALAMEDA, Calif., June 11, 2026 /PRNewswire/... ► Artikel lesen |